Drawing for OHC OSANG HEALTHCARE

USPTO serial 88500869

OHC OSANG HEALTHCARE

Reviewed by CopyMark Law Group

Reg. 6269246Status 700Renewal
Filing date
Status date
Registration date
Feb 16, 2021
Examiner
FALK, JONATHAN ROBERT
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with OHC OSANG HEALTHCARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Alumit

John Alumit ALUMIT IP135 S. JACKSON STREET, SUITE 200GLENDALE, CA 91205UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medical diagnostic test strips for diabetics; Medical diagnostic test reagents for diabetics; medical diagnostic test kit comprised of medical diagnostic reagents and assays for testing viral infections; Diagnostic test reagents for veterinary purposes; Medical diagnostic reagents for use in genetic diseases testing; Medical diagnostic test reagents for use in genetic diseases testing; Medical diagnostic strips for glycated hemoglobin; Medical diagnostic test reagents for blood glucose; Medical diagnostic strips for liver disease; Medical diagnostic test reagents for liver disease; Medical diagnostic test reagents for glycated hemoglobin; Reagent paper for medical purposes; Medical diagnostic strips for cardiac disease; Medical diagnostic test reagents for cardiac disease; Medical diagnostic test reagents for cancerous diseases; Medical diagnostic strips for cancerous diseases; Medical diagnostic strips; Diagnostic test reagents for medical purposes; Diagnostic agents for medical use; Medical diagnostic test reagents for cholesterol; Medical diagnostic strips for cholesterol; Medical diagnostic strips for blood glucose; Reagents for clinical medical tests; Diagnostic kit comprised of medical diagnostic reagents and assays for testing contagious infection symptomsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 16, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Feb 16, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 13, 2021DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Dec 22, 2020IUCNNOTICE OF ALLOWANCE CANCELLED—
Dec 22, 2020D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Dec 22, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 27, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 27, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 7, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 22, 2020FIXDELECTRONIC RECORD REVIEW COMPLETE—
Sep 18, 2020ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Sep 11, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 18, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 18, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 16, 2020ALIEASSIGNED TO LIE—
Jul 29, 2020ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Mar 11, 2020GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 11, 2020GNSLLETTER OF SUSPENSION E-MAILED—
Mar 11, 2020CNSLSUSPENSION LETTER WRITTEN—
Mar 10, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 9, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 9, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 30, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 30, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 30, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 23, 2019DOCKASSIGNED TO EXAMINER—
Sep 3, 2019DPCCDIVISIONAL PROCESSING COMPLETE—
Aug 27, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 13, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 11, 2019DRRRDIVISIONAL REQUEST RECEIVED—
Jul 11, 2019ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Jul 8, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance